InfuSystem Holdings Inc (INFU)
AMEXHealth CareMedical - DevicesSnapshot 2026-09-04
$12.24+0.49%
Close 2026-09-04 · 1-day change
AMEXHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · INFU
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 7.5% |
| Our one-year growth estimate | diamond | 5.6% |
Growth built into the price is above our model estimate.
The price assumes 1.9 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Model as of 2026-09-04 · Compared with 87 industry peers · Company calendar date is not available
INFU — Chair transition
Dated 2026-05-14
Chairman of the Board of Directors — Beverly Huss: Beverly Huss was elected as the new Chairman of the Board of Directors.
Why it matters: Updates will show if InfuSystem can reach its revenue goals. This is important after declines.
Supportive ifManagement confirms pro-forma revenue growth of 6% or more for 2026.
Worry ifManagement cuts expected revenue growth to less than 4% for 2026.
Why it matters: News about the stock buyback program shows management's trust in the company's worth.
Supportive ifAnnouncement of stock buybacks worth $20 million.
Worry ifNo updates or delays in the stock repurchase program.
Why it matters: A strong EBITDA margin helps profits and builds trust with investors.
Supportive ifAdjusted EBITDA margin stays above 22% in Q3.
Worry ifAdjusted EBITDA margin drops below 20% in Q3.
Why it matters: Management aims for 6% to 8% revenue growth for 2026. Meeting this would show recovery from Q1 declines.
Supportive ifQ2 2026 revenue growth meets or exceeds 6% year-over-year.
Worry ifQ2 2026 revenue growth falls below 6% year-over-year.
Why it matters: Keeping the EBITDA margin in the mid to low 20% is key for making money.
Worry ifAdjusted EBITDA margin is over 22% in Q2. This shows good cost control.
Less concerning ifAdjusted EBITDA margin is under 20%. This means costs are rising or there are problems.
Why it matters: If revenue growth speeds up, it may signal a stronger health care market. This could benefit InfuSystem.
Supportive ifHealth care sector revenue growth is speeding up again. It is close to 10% year over year.
Worry ifRevenue growth keeps slowing down. It is now below current levels.
Why it matters: Device Solutions revenue needs to stabilize or grow after recent drops.
Watch forDevice Solutions revenue shows growth or stabilizes in Q3.
Also watch forDevice Solutions revenue drops more in Q3.
Why it matters: Strong growth in Patient Services shows demand for at-home therapies. This is key for future earnings.
Supportive ifPatient Services revenue will grow more than 15% year over year in the next quarters.
Worry ifPatient Services revenue growth falls below 10% YoY.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$171 on $10,000 · ±1.7% | How much price usually moves either way. |
| Bad day | $464 loss on $10,000 · 4.6% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $2,947 loss on $10,000 · 29.5% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.